The latest issue of CURE is a special one devoted to immunotherapy, such as Keytruda (which is being
increasingly used to treat metastatic bladder cancer.)
www.curetoday.com/publications/cure/2018/immunotherapy-special-issue
Found several of the articles very interesting.
(DISLAIMER: I am not a big fan of this publication, particularly because I find the ads offensive. I guess someone
has to pay for it
! However, this series of articles is really appropriate to those interested in bladder cancer.)